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MEASURES THAT MATTER
ABSTRACT
Measurements that Matter: Assessment and Management of the Symptoms of
Chronic Illness Using the Integrated Palliative Outcome Scale (IPOS)
Background: The mission of the Advanced Illness Management (AIM) program at the
Visiting Nurse Association of Greater St. Louis (VNA) is to relieve the burden of serious
illness by providing exceptional care to patients and families through symptom
management. A validated symptom tool was needed for holistic assessment.
Purpose: This is a quality-improvement project aimed at enhancing symptom
management in patients experiencing advanced illness in a community-based palliative
care program. Provider use of the Integrated Palliative Outcome Scale (IPOS) as an
assessment tool to deliver focused interventions was explored.
Methods: The IPOS tool was embedded in the Electronic Health Record (EHR) note
template. The project used the PICO framework to identify the problem. The Population
of interest were new patients admitted during a 90 day period. The Intervention of
interest was the use of the IPOS by providers. The Comparison of interest was the
absence of the IPOS prior to the project. The Outcome of interest was the use of the IPOS
and documentation of interventions.
Results: There were 62 visits in the sample. Compliance rate with use of the tool was
93.5%. Poor mobility and weakness were the most common physical symptoms. The
most common psychosocial symptom was the patient’s perception of family anxiety.
Poor mobility and weakness scored the highest number of aggregate symptoms: 39 and
37 times respectively. Providers intervened 74% and 76% of the time. While providers
responded 100% of the time to overwhelming immobility, overwhelming weakness only
received an intervention 66% of the time. The highest number of psychosocial/spiritual
symptoms was the patients’ perception of family anxiety. Thirty positive responses were
recorded with an aggregate score of 76% interventions. The patients’ own anxiety/worry
was recorded 17 times with an aggregate intervention score of 88%.
Conclusions: Community-based palliative care programs need to be pro-active in the
management of symptoms to provide holistic patient-centered care. This project used a
validated tool that addresses not only the physical burden of chronic illness, but the
emotional, mental, spiritual, and relationship aspects of illness.
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Introduction
Advanced Illness Management (AIM) is defined as “occurring when one or more
conditions become serious enough that general health and functioning decline, and
treatments begin to lose their impact. This is a process that continues to the end of life”
(American Hospital Assoc., n.d.). Providers of AIM care must have experience in
assessment, evaluation, diagnosis, and treatment of advanced illness and be
knowledgeable of cultural and ethical situations involving patients and families.
Individual providers approach to assessing symptom management created the need for
consistent documentation which provides information to the interdisciplinary team. The
Visiting Nurse Association of Greater St. Louis (VNA) has developed a communitybased AIM program that addresses chronic disease in the elderly and disabled adult
population in the St. Louis metropolitan region. Providers work within an
interdisciplinary team model to provide quality care with measurable outcomes. The
program is a team-based consultation co-management program based on a palliative care
model. Palliative care was eliminated in the title of AIM as the general public has an
immediate association with end-of-life care and terminal disease. In reality, palliative
care is for any patient with chronic illness who is experiencing a decreased quality of life
because of symptoms related to their illnesses or treatments (Mulvihill, 2014).
Palliative care (PC) is defined as, “Specialty medical care for people living with
serious illness. It focuses on providing relief from the symptoms and stresses of serious
illness whatever the diagnosis. The goal is to improve quality of life for both the patient
and family” (California State University Institute for Palliative Care, n.d.) Patients have a
high burden of symptoms that may be physical, emotional, spiritual, mental, or
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relationship/social in nature. In many cases of advanced illness, patients are not eligible
for hospice or choose not to utilize hospice services if eligible. Patients may seek curative
treatments concurrent with AIM care. Evidence-based treatments and processes aimed at
quality improvement are necessary to ensure that care is provided appropriately
regardless of the trajectory of illness. This paper describes a quality improvement project
aimed at improving symptom management of patients experiencing advanced illness. A
symptom tool was needed due to incomplete and inconsistent documentation by
providers of interventions related to positive symptoms. Provider use of the Integrated
Palliative Outcome Scale (IPOS) for a select patient population was explored.
The VNA community-based AIM Program is a grant-funded project of the
Missouri Foundation for Health. The mission of the AIM Program is to help relieve the
burden of serious illness by providing exceptional care to patients and families through
symptom management. The program prepares patients and families to transition along
life’s continuum, and prepare for end-of-life when the time is appropriate. Stated goals
related to grant-funding are that the project demonstrates its ability to provide quality and
cost-effective care in the area of symptom management. Prior to this project, providers
were trained to ask about pain, shortness of breath, and sleep habits during visits. These
answers were “yes” and “no” responses or often not documented. This caused a gap in
care and limited opportunities for team member follow up. There was no method for
recording psychosocial symptoms that are important to holistic care. A validated
assessment tool needed implementation by providers to screen patients for timely
interventions from the interdisciplinary team.
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For this project, the IPOS has been embedded in the electronic health record
(EHR) at a community-based palliative care specialty practice. The purpose of
incorporating the IPOS into the EHR progress notes was to promote consistency in
assessment and management of symptoms related to advanced illness by healthcare
providers on the team. The IPOS tool has been developed over the past 15 years in
palliative care settings worldwide. Patient related outcome measures (PROMs) are
measures that reflect quality of life for patients and families dealing with the burdens of
serious illnesses in the community. Use of IPOS allows providers to respond to PROMs
by providing timely interventions related to patients’ reported symptoms.
The problem statement is: a consistent and systematic holistic symptom
assessment tool was needed to manage a gap in care. The IPOS is a validated symptom
tool for management of patients in a community-based palliative care program. The
PICOT question used to guide this evidence-based project was: “For chronically ill
patients, will use of a validated symptom tool improve providers’ responses to patient
symptoms?” The population of interest (P) is all newly enrolled patients in the AIM
program at the VNA December 1, 2017 – February 28, 2018. The intervention of interest
(I) is the use of the IPOS tool by providers on all new patients admitted between
December 1, 2017 – February 28, 2018. The comparison of interest (C) is the absence of
use of the IPOS at the VNA prior to December 1, 2017. The outcome of interest (O) is
the use of the IPOS and documentation of interventions (when indicated) by providers for
the selected population and timeframe. The project was implemented December 1, 2017 –
February 28, 2018. The first goal of care is stated in the Top Ten Measures that Matter
(AAHPM, 2015): Palliative care patients receive a comprehensive assessment (physical,
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psychosocial, social, spiritual, and functional) soon after admission. These goals are
ongoing in the plan of care for patients. The purpose of this quality improvement project
was to enhance symptom management for patients in the AIM program. Provider use of
the IPOS to deliver focused interventions was explored.
An audit tool was developed to review progress notes on provider visits occurring
for 90 days on all visits including the initial visit. The selected new patient population
was followed for 90 days after admission. Patients typically received 4 visits in the 90
day period after admission.
Review of the Literature
An extensive review of the literature regarding the use of outcome measures for
control of symptoms in palliative care was done using the following databases: PubMed,
Medline, CINAHL, Ovid, and Google Scholar. The keywords: palliative care, outcome
measures, symptom management, symptom management tools, POS, and IPOS were
used. Search years were 2000 to the present. The search resulted in approximately 90
documents inclusive of controlled trials, studies, white papers, policy statements, and
consensus reports. Trials and papers that were conducted in hospital and office-based
programs were excluded.
The literature was also reviewed for palliative care guidelines that provide
processes for development of quality models. The American Academy of Hospice and
Palliative Medicine report on Ten Measures to Drive Quality Palliative and Hospice
Care, AAHPM (2015), provides strong evidence that the development of benchmark
outcome measures must include validated tools for symptom management. The basis for
quality palliative care is defined in the National Consensus Project for Quality Palliative
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Care (Ferrell et al., 2007) and describes the eight domains of care that define palliative
care. The domains of care should be explored to care for patients and families in a
holistic team setting. The domains of care identify symptom management as the key
indicator for successful outcomes.
In addition to the National Consensus Project for Quality Palliative Care (2013),
several papers and research studies offer strong evidence that community-based palliative
care programs are valuable programs in management of patients with serious chronic
illnesses who have difficulty leaving the home. Cohn et al. (2017) published a discussion
paper that validates community-based palliative care in the management of chronically ill
patients. Higginson, Hart, Koffman, Selman, & Harding (2007) conducted a systematic
review in 2006 that develops the basic need for palliative care as a discipline in
healthcare.
In a Cochrane systematic review completed by Gomes, Calazani, Curiale,
McCrone, and Higginson (2012), the effectiveness and cost-effectiveness of home-based
palliative care as an option for adults with advanced illness and their caregivers was
discussed. The importance of symptom management as it related to quality of life is
reviewed. Leff, Carlson, Saliba, and Richie’s 2015 article on the state of home-based
primary and palliative care in the United States (U.S.) led them to create the National
Home-Based Primary and Palliative Care Network. The authors have developed a
registry that will be used for quality care benchmarking, practice-based quality
improvement, performance reporting, and comparative effectiveness research. The main
focus of the quality of life domain is to optimize symptom management.
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Lorenz et al. (2006) conducted a systematic review on measures for symptoms
and advanced care planning in cancer patients. Measures related to pain, dyspnea,
depression, and advanced care planning are linked to quality of life measures in cancer
patients. Muldoon, Barger, Flory, and Manuck (1998), discussed quality of life as it
relates to the personal burden of illness and part of the psychosocial aspects of illness.
This study is one of the early studies that directed a great deal of research toward quality
of life issues in palliative care.
Bauseweine et al. (2011) interviewed providers to determine usage of outcome
measures. The results indicate that measurement tools need to be easy to use and
convenient to interpret to be used consistently. Providers indicated that the most common
reason that tools are not used is that they do not have time to administer them.
The symptoms of serious illnesses dramatically affect the quality of life of
patients and caregivers. The symptoms associated with serious illness can be physical,
mental, emotional, spiritual, or psychosocial. This creates the necessity of the use of a
tool that addresses symptoms in a holistic process. A tool that is validated for use in
multiple illnesses and with diverse populations was needed to produce data useful to
providers and results in appropriate interventions. Additionally, a tool that has been
validated in multilingual settings is needed for diverse cultures and ethnicities. The
Integrated Palliative Outcome Scale (IPOS) (Appendix) was originally developed at
King’s College in London, UK. POS: Palliative Outcome Scale (2012) is the IPOS
precursor and has been tested extensively in Europe and Africa. It has been revised and
refined over a 15 year validation period. Literature on the validity of the IPOS was
reviewed to determine its appropriateness for use in a community-based program that
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manages multiple serious chronic illnesses in private homes as well as long-term care
settings.
The current literature offers strong evidence that the IPOS is a valid tool for use in
multi-cultural settings for multiple illnesses in palliative care settings. The following
studies were reviewed as they relate to IPOS use in various palliative care settings.
Evans et al. (2013) assert that PROMs are the most useful outcome measures to
determine patient quality of life in consensus workshop studies. The Palliative Outcome
Scale (precursor) to IPOS is specifically cited as a valid tool to measure PROMs. Collins
et al. (2015) conducted a systematic review of the use of the POS and the Support Team
Assessment Schedule (STAS), which found support of these as valid tools in a variety of
palliative care settings. Kane et al. (2017) evaluated the acceptability and feasibility of
the IPOS in symptom management of heart failure patients in palliative care programs.
They concluded that the IPOS is a valid tool for symptom management in heart failure.
This is a notable study due to the high number of heart failure patients in palliative care
programs.
Studies using the POS include the 1999 study by Hearn and Higginson who
developed a scale to measure the physical, psychological, and/or spiritual domains of
palliative care and tested it for validity on 450 patients with advanced cancer. This study
was the basis for continued development of the POS as a validated tool to measure
symptom burden. Lowther et al. (2012) used the POS in a randomized controlled trial
(RCT) to measure symptom burden in HIV patients receiving antiretroviral therapy.
Evans et al. (2013) identify the POS as a valid tool to measure PROMs by international
experts attending a palliative care and end-of-life consensus workshop. Rugno and
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Marysia (2016) conducted an integrated literature review of 25 multi-cultural studies that
validates the importance of the POS in research studies in palliative care. The review also
included validity of the POS in clinical practice for symptom management.
Beck et al. (2017) validated the translation of the IPOS into Swedish. The IPOS
was successfully adapted cross-culturally in general and specialized palliative care.
Schildmann et al. (2015) validated the translation of the IPOS into German. Results from
these studies also validate that the tool is acceptable translated into specific cultural
settings.
In 2016, Gao et al. used the IPOS with additional neurological emphasis
successfully in a small study. This validated that the IPOS can be modified for use in
specific patient populations. A specific IPOS for patients with progressive long-term
neurological illnesses showed reasonable correlation with the original POS. The use of a
specific IPOS tool for research purposes in monitoring outcomes over time in
neurological diseases shows promise for detecting subtle progression of illness and slow
decline.
Kane et al. (2017) used the IPOS in a large heart failure study that not only
validated outcome measures, but a high compliance of provider use was recorded. The
heart failure study had two parts. The first included education and training on patientcentered care, and the second part trained nurses on the use of the IPOS for heart failure
patients. Murtagh et al. (2016) showed that the IPOS has good test-retest reliability and
internal consistency. The IPOS was used in a Cochrane controlled trial for patients
completing the questionnaire with their caregiver proxies. Clinical relevance was
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established by higher scores by both patients and proxies in unstable or deteriorating
disease states.
The IPOS literature review includes strong evidence that the IPOS is a valid tool
in palliative care specialties for measurement of the burden of symptoms. The IPOS was
developed from the POS integrating the most clinically relevant aspects of quality of life.
Symptoms may be physical, mental, emotional, spiritual, or psychosocial in nature. The
tool has also been validated for use in multiple types of serious and/or chronic illnesses.
The IPOS has been extensively used in studies conducted in Europe and Africa. There are
gaps in studies on the use of the IPOS in the U.S. There is also a gap in studies that
involve individuals affected by advanced dementia.
Framework of the Study
The framework of this study is the Plan, Do, Study, Act framework (Institute for
Healthcare Improvement, n.d.) In the Plan phase, research was done on the validity of the
IPOS as it not only addressed physical symptoms, but contained narratives necessary to
understand the emotional, spiritual, psychosocial, mental, and relationship needs of
patients and families facing serious and/or chronic illnesses in the community. Also,
during the Plan phase, rights were obtained to use the tool in the practice setting and for
research purposes. The information technology support team was engaged in the project
to embed the tool into the EHR as a custom report that would allow quick and easy
access by providers. The IPOS appears in the provider progress note and requires
approximately five minutes to complete. Results can be exported to custom reports after
de-indentification for recording and research purposes.
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In the Do phase, training sessions for providers was accomplished in two sessions
to provide adequate opportunity to discuss the use and importance of the tool in the
practice to provide high quality of care to patients and families. The go-live date of
December 1, 2017 was chosen to allow a 90 day period of collection for retrospective
review on use and associated interventions in positive symptom burdens. Consistent use
of the tool and interventions were audited following the initial period of use.
A 90-day Study phase began at the go-live date. Providers were instructed that the
IPOS should be used during each visit on any newly admitted patient to the VNA AIM
program from December 1, 2017 – February 28, 2018. Patients in the study were audited
for all visits done in the 90 days following their admission.
After the 90-day Study, results of the audit were reviewed during the Act phase.
The Act phase began with an EHR review of the target patient population. Provider notes
were reviewed for appropriate use of the IPOS and documentation of corresponding
interventions when indicated. Retraining and continued education of the providers will be
done post-audit via team meetings to reiterate the significance of symptom management
and to discuss implementation of goals of care six months following the audit period.
Method
Design
This is a quality improvement project. Retrospective chart audits were completed.
The IPOS was used by clinical providers during visits on all new patients in the AIM
program. Patients included in this project were admitted as new patients between
December 1, 2017 and February 28, 2018. Documentation of results of the IPOS was
recorded in the patient’s EHR during the provider visit. The provider verbally read the
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questions to the patient during the visit and recorded the answers. The go-live date for
implementation of the project was December 1, 2017. Beginning June 1, 2018, eligible
patient EHRs were audited for provider compliance in the use of the IPOS and
documentation of corresponding interventions for positive responses. Caregiver
assistance if given, was documented on the IPOS.
Setting
The setting for the project was a community-based palliative care specialty
practice. Patients were primarily over 65 years of age or disabled adults who were
enrolled in VNA of Greater St. Louis AIM program. The patients or an approved
designee signed consent forms to be treated by the providers and interdisciplinary team
members of the AIM program. Provider visits occurred in the patient’s primary residence,
which may be a private home, long-term facility or senior housing.
Sample
The target population for this quality improvement project was all new patients
admitted to the AIM program between December 1, 2017 and February 28, 2018. Patients
qualifying for the program were 65 years and older or disabled adults with one or more
chronic and/or serious illnesses. Patients were insured by Medicare, Medicaid or
sponsored by the VNA. Patients were not excluded due to gender, race, ethnicity or
sexual orientation. Patients who scored less than 7 on the 10-point cognitive screen with
the Rapid Geriatric Assessment Tool (RGAT) (St. Louis University, 2016) were excluded
from this project. The patient sample size was 17 patients. Each patient received
approximately 4 visits in the 90 day intervention period. Patients who transitioned out of
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the program during the audit period, received less than 4 visits. All chart audits were
completed by the project director with the audit tool created for this project.
Approval Processes
Providers of care and interdisciplinary team members have been notified of the
study and the go-live date for use of the IPOS. Consent of the patient or approved legal
designee to participate in the AIM program is obtained on admission. This is a noninvasive intervention. Information obtained from the tool will be used to improve the
delivery and quality of care related to symptom management in advanced illness. The
project was approved by the University of Missouri – St. Louis Institutional Review
Board.
Data Collection/Analysis
Chart reviews for provider compliance with the use of the IPOS for assessment
and management of symptoms related to the burden of serious illness were conducted by
the project director on encrypted computers in a cloud-based EHR. A de-identified
number was assigned by the auditor to each patient audited. Audits of patient records
were performed using the EHR by the auditor authorized to use the system. The deidentified audit tools were paper records stored in locked cabinet at the VNA office. All
chart audits occurred at that location. Compliance with the use of the IPOS tool and
documentation of corresponding interventions for positive responses was recorded on the
audit tool. The audit results will be used to improve care delivery and the quality of life
for patients experiencing advanced illness.
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Procedures
This is a quality improvement project that included a retrospective chart review
on all new patients enrolled in the AIM program at VNA of Greater St. Louis between
December 1, 2017 and February 28, 2018. Patient provider visits occurring 90 days
following the initial enrollment received chart reviews by the project director. The audit
tool was developed by the project director to mirror the symptoms on the IPOS tool.
The following was evaluated per the audit tool: provider use of the IPOS, patient
responses, and provider documentation of corresponding interventions when indicated.
Patient responses to inquiries about pain, shortness of breath, weakness, nausea,
vomiting, poor appetite, constipation, sore or dry mouth, drowsiness, and poor mobility
that were recorded as “Moderately,” “Severely,” or “Overwhelmingly,” should have a
corresponding intervention. Additionally, patient responses to “other” symptoms
recorded as “Moderately” or greater should have a corresponding intervention. Patient
responses to questions related to the last 3 days prior to use of the IPOS regarding patient
anxiety, family anxiety, and patient depression should have a provider intervention to
responses of “Most of the time” or “Always”. Patient responses to questions about feeling
at peace, sharing feelings with family and friends, and having as much information as
wanted should have a corresponding intervention recorded in the Plan section if the
response is “Occasionally” or “Almost never”. Patient responses of “Problems hardly or
never addressed” to the question regarding financial or personal problems addressed
should have a corresponding intervention in the Plan section. The audit tool recorded the
patient’s diagnosis, but no identifying demographics. Each provider in the AIM program
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who participated in this project was assigned an identifier to assess patterns of variability
across providers and for individual education purposes. The end goal is the delivery of
consistent, quality care.
Results
Table 1 Patient PopulationTotals

Total patients in project

17

Number of Initial Visits in project

17

Second Visits

15

Third Visits

15

Fourth Visits

12

Fifth Visits

3

Total Visits

62

Total Visits using IPOS resulting in

58

93.5% compliance during audit

During the 90-day enrollment period, 20 new patients were enrolled to the AIM
program. Three patients were excluded due to cognitive scores below seven on St. Louis
University’s RGAT, (St. Louis University 2016). The sample for this project was 17.
There were 62 visits in the sample and 58 of these had completed IPOS. This is a 93.5%
compliance rate of providers’ use of the tool.
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An unexpected result was that five patients transitioned to end-of-life care before
the 90-day audit ended. These patients did not receive the expected four visits in the
period.
Table 2 Patient Population by Diagnosis
Primary Diagnosis
CHF

6

35%

Cancer (all sites)

4

24%

COPD/Asthma

2

12%

Interstitial Lung Disease

2

12%

Other

3

17%

Patient population results showed 35% were admitted with a primary diagnosis of
Congestive Heart Failure (CHF). 24% were admitted with cancer, and 24% with lung
diseases (Chronic Obstructive Pulmonary Disease, COPD was 12% and interstitial lung
disease was 12%). The remaining 17% included caregiver stress, failure to thrive, and
chronic pain. The majority of the patient population had multiple chronic illnesses that
were co-managed by the primary care providers.
The rating scale in the IPOS for symptoms increase as the burden of the symptom
increases. For physical symptoms, moderate equaled two points, severe equaled three
points, and overwhelming equaled four points. Poor mobility and weakness were the
most common physical symptoms, positive more often than pain or shortness of breath.
These two symptoms were reported in all diagnoses as the most burdensome physical
symptoms. The audit of interventions in response to physical symptoms was for
symptoms scored moderately, severely or overwhelmingly. Patients’ perceptions of
family anxiety about their illnesses was the most common psychosocial symptom, rated
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more often than the patients’ own anxiety. Interventions were expected in the audit when
symptoms were rated most of the time or always. While patient anxiety is addressed 88%
of the time by providers, family anxiety is addressed 76% of the time. When providers
asked patients about “Peace,” 17 patient visits recorded that they were only occasionally
or almost never at peace. Generating meaningful discussions with patients and caregivers
to concerns about the concept of peace, and referring to spiritual counselors as indicated
allows patients to begin transitioning to end-of-life care.
Provider interventions for aggregate levels of physical symptom burdens ranged
from 100% for vomiting to 14% for constipation and sore/dry mouth. When constipation
was scored as moderate with 2 points assigned for each response and intervention,
moderate constipation was 17% and severe constipation received 0% interventions.
Moderate sore/dry mouth had 0% interventions and severe sore/dry mouth received
interventions 43% of the time. Due to the adverse effects of these symptoms on patients’
quality of life, education on guidelines and protocols will be reviewed with providers as
part of future recommendations.
Poor mobility and weakness scored the highest number of aggregate symptoms:
39 and 37 times respectively. Providers intervened 74% and 76% of the time. While
providers responded 100% of the time to overwhelming immobility, overwhelming
weakness only received an intervention 66% of the time. Table 3 shows the intervention
percentages for physical symptoms. Percentages in bold are below the standard of care
percentages that will be established as a result of this baseline audit.
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Table 3 Percentage of Interventions in Response to Positive Physical Symptoms
#

Aggregate %

Moderate %

Severe %

Overwhelming %

85%

90%

95%

Pos.
Symptom/Goal

Pain

30

90%

95%

75%

100%

SOB

29

79%

80%

86%

-

Weakness

37

76%

68%

87%

66%

Nausea

6

67%

75%

50%

-

Vomiting

1

100%

100%

-

-

Poor

16

50%

33%

71%

-

Constipation 7

14%

17%

0%

-

Sore/Dry

14

14%

0%

43%

-

Drowsy

16

63%

58%

75%

-

Poor

39

74%

78%

60%

100%

8

63%

43%

100%

-

Appetite

Mouth

Mobility
Other

Notes: Percentages in bold are below the proposed 6 month goals of:
Moderate= Intervention at least 85% of the time. Severe= Intervention at least 90% of
the time.
Overwhelming= Intervention at least 95% of the time.
Items marked with (-) indicate that no data was generated in the audit
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The highest number of psychosocial/spiritual symptoms was the patients’
perception of family anxiety. Thirty positive responses were recorded with an aggregate
score of 76% interventions. The patients’ own anxiety/worry was recorded 17 times with
an aggregate intervention score of 88%

Table 4 Percentage of Interventions in Response to Positive Psychosocial
Symptoms
# Pos.
Aggregate %
Most of the
Always %
Time %
SYMPTOM/GOAL

90%

95%

Anxiety/Worry

17

88%

89%

87%

Family Anxiety

30

76%

75%

78%

Depressed

13

77%

70%

100%

Notes: Percentages in bold are below the 6 month goal of Intervention at least
90% for Most of the time, and Intervention at least 95% for Always.
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Percentage of Interventions in Response to Positive Psychosocial Symptoms
# Pos.

Aggregate %

Occasionally %

Not at
All %

SYMPTOM/GOAL

90%

95%

Peace

17

88%

91%

83%

Family Sharing

7

86%

100%

80%

Info. Sharing

1

100%

100%

None

Notes: Percentages in bold are below the 6 month goal of Intervention at least
90% for Occasionally, and Intervention at least 95% for Not at All.

Percentage of Interventions in Response to Positive Psychosocial Symptoms
Aggregate %

SYMPTOM/GOAL
Practical

-

Hardly

Never

Addressed %

Addressed %

90%

95%

-

-

Problems
Notes: No patient symptoms were reported at these levels on this audit.
Indicated with (-).
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Discussion
Community-based palliative care programs need to be pro-active in the
management of symptoms to provide holistic patient-centered care. This project uses a
validated tool (IPOS) that addresses not only the physical burden of chronic illness, but
the emotional, mental, spiritual, and relationship aspects of illness. The project was
heavily weighted toward the documentation of the full-time AIM providers as they
perform the majority of the patient visits in the first 90 days. It is by program design that
the two most experienced providers provide consistent stabilization of patients
immediately after admission when they are at the highest risk of hospital readmission. An
unexpected result of patients transitioning to hospice during the audit period decreased
the expected number of visits during the 90-day audit period.
Subsequent audits will need a comprehensive review of all providers as the
program grows and new providers and census increase. Future training on the use of the
IPOS needs to incorporate the experience of staff who have consistently administered it
successfully over the 90-day audit period. Providers consistently used the tool in 93.5%
of their visits. Incorporating the tool in a conversational review of symptoms often
generated narrative from patients that aided providers in determining decreased coping by
patients and/or increased caregiver stress and anxiety. Providers indicated that the tool
was not too time consuming, and it triggered reminders of documentation of positive
symptoms.
This audit will be used to formulate a quality improvement initiative within the
AIM program to be reviewed 6 months post-baseline audit on individual providers’
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intervention response to symptoms. A second 90 day audit will be performed on random
visits for individual providers after education on the expected percentages of intervention.
This project provides the AIM program with a valid baseline on provider responsiveness
to symptom burden in chronically ill patients across all admitting diagnoses. Providers
administered the IPOS during 93.5% of their visits during the 90-day audit period. The
goal in six months is to maintain a 95% administration rate for all providers. Goals for
physical symptoms at 6 months is 95% of patients receive interventions for symptoms
rated as overwhelming, 90% for symptoms rated severe, and 85% for symptoms rated
moderate. The six month goal for the psychosocial symptoms of patient anxiety, family
anxiety and depression rated most of the time is 90% of patients receive interventions and
if rated always is 95%. Psychosocial symptoms of peace, family sharing of feelings and
information rated as occasionally receives an intervention 90% of the time, and if rated
not at all 95%. Problems hardly addressed receive an intervention 90% of the time.
Problems not addressed receive an intervention 95% of the time. Implementation of these
goals will guarantee consistent quality of life through timely symptom management.
Dementia patients scoring less than 7 on the Rapid Geriatric Screen (St. Louis
University, 2016) were excluded from this project. This exclusion of three patients in the
90-day audit generates an opportunity to conduct another project using IPOS
administered to caregiver proxies during visits in comparison to a tool specifically
designed for dementia patients.
An integral part of the success of the program is the telephone “touch” calls
completed by the medical secretary. The IPOS page 1 was integrated into the telephone
encounter form when doing status checks. This allows consistent management with each
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encounter. Consistent themes during a series of encounters allows providers to direct
interventions toward recurring problems.
The most common physical symptoms that patients reported were poor mobility
and weakness. These two symptoms were reported in all diagnoses as the most
burdensome physical symptoms. The audit of interventions in response to physical
symptoms was for symptoms scored moderately, severely or overwhelmingly. Patients’
perceptions of family anxiety about their illnesses was the most common psychosocial
symptom, rated more often than the patients’ own anxiety. Interventions were expected in
the audit when symptoms were rated most of the time or always. While patient anxiety is
addressed 88% of the time by providers, family anxiety is addressed 76% of the time.
When providers asked patients about “Peace,” 17 patients stated that they were only
occasionally or almost never at peace. Generating meaningful discussions with patients
and caregivers to concerns about the concept of peace, and referring to spiritual
counselors as indicated allows patients to begin transitioning to end-of-life care.
Education for providers on the availability of resources that can easily be
accessed is indicated from the low intervention scores on some symptoms. This resource
list would include all AIM and community partners to be used as resources when positive
physical and psychosocial symptoms are noted. These team and partner resources may
include behavioral health, physical and occupational therapy, home infusion, laboratory
and radiology home services, and many others. Part of the commitment to effective home
management is a network of services to address symptoms in all domains of care.
The next step in improving the quality of care is re-educating providers on the
importance of interventions relating to positive symptoms expressed by patients.
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Interdisciplinary team members need education on interpretation of positive symptoms
revealed in their domains of specialty. Integration of the IPOS for tracking outcomes over
time increases the importance of corresponding interventions to provide quality care over
time. The symptoms addressed in IPOS page 1 have already been embedded in the
telephone encounter form. This extends the opportunity of addressing the possibility of
positive symptoms at every encounter with the AIM team. Future projects include
researching guidelines and best practices for managing individual symptoms that
emerged in common themes from this project in order to provide consistent interventions
among providers.
Guidelines can be inserted in the patient’s care plan. They include pharmaceutical
and non-pharmaceutical teaching interventions. Implementation of these guidelines and
best-practices help establish patient-centered goals of care and empower patients’ and
families’ autonomy.
Conclusion
Community-based programs managing chronic illnesses as specialty palliative
care is a new and growing concept in U.S. healthcare. The AIM program in St. Louis is
funded by the Missouri Foundation for Health to test quality, patient satisfaction, and
cost-effectiveness. AIM will not only be judged using the Institute for Healthcare
Improvement’s Triple Aim of improving the health of populations, patient-centered care,
and cost-effectiveness, (Institute for Healthcare Improvement, n.d.), but for sustainability.
Outcomes can be improved by effective symptom management that satisfies the Institute
of Medicine’s goals for the patient’s experience of care: safe, effective, efficient, timely,
equitable, and patient-centered (Institute of Medicine, 2016). Data collected from IPOS
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audits will drive guidelines and best-practice information to assist providers in providing
consistent, quality patient care. Information will be obtained from Joint Commission,
Institute of Medicine, and the Center for the Advancement of Palliative Care to assist in
certification of the AIM program as the specialty grows in U.S. healthcare programs.

27
MEASURES THAT MATTER
References

American Academy of Hospice and Palliative Medicine: (Feb. 16, 2015). Ten measures
to drive quality palliative and hospice care. Retrieved at:
www.aahpm.org/uploads/homepage/MWM_Release.pdf
American Hospital Association (n.d.) Advanced Illness Management Strategies-Part 1.
Retrieved at: http://www.aha.org/about/org/aim-strategies.shtml
Bauseweine, C., Simon, S., Behalia, H., Downing, J., Mwangi-Powell, F., Daveson, B.,
Harding, R., & Higginson, I. (2011). Implementing patient reported outcome
measures (PROMs) in palliative care – users’ cry for help. Health Quality of Life
Outcomes; 9:27. Published online April 20, 2011. DOI: 10.1186/1477-7525-9-27
Retrieved at:
http://europepmc.org/articles/PMC3112059;jsessionid=64E04CBC81F6981AF13
03D6533A8BEBC
Beck, I., Moller, U.O., Malmstrom, M., Klarare, A., Samuelsson, H., Hagelin, C.L,
Rasmussen, B., & Furst, C.J. (2017). Translation and cultural adaptation of the
integrated palliative care outcome scale including cognitive interviewing with
patients and staff. BMC Palliative Care; 16:49. Published online Sept. 11, 2017.
DOI: 10.1186/s12904-017-0232-x Retrieved at:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594532/
California State University Institute for Palliative Care (n.d.). Palliative Care EducationAnytime, Anywhere, Mapping Your Success in Palliative Care. Retrieved at:
https://www.csupalliativecare.org/palliativecommunity/what-is-palliative-care/

28
MEASURES THAT MATTER
Cohn, J., Corrigan, J., Lynn, J., Meier, D., Miller, J., Shega, J. & Wang, S. (2017).
Community-based models of care delivery for people with serious illness.
Perspectives: National Academy of Medicine. Retrieved at:
https://nam.edu/community-based-models-of-care-delivery-for-people-withserious-illness/
Collins, E., Witt, J., Bauseweine, C., Daveson, B., Higginson, I. & Murtagh, F. (2015). A
systematic review of the use of the palliative care outcome scale and the support
team assessment schedule of palliative care. Journal of Pain and Symptom
Management; 50:6 pp. 842-853. Retrieved at:
https://www.ncbi.nlm.nih.gov/pubmed/26335764
Evans, C., Benalia, H., Preston, N., Grande, G., Gysels, M., Short, V., Daveson, B.,
Bauseweine, C., Todd, C. & Higginson, I. (2013). The selection and use of
outcome measures in palliative and end-of-life care research. The MORECare
international consensus workshop. Journal of Pain and Symptom Management;
46:6 pp. 925-937. Retrieved at: https://www.ncbi.nlm.nih.gov/pubmed/23628515
Ferrell, B., Connor, S.R., Cordes, A., Dahlin, C., Fine, P.G., Hutton, N. et al. (2007).
National Consensus Project for Quality Palliative Care Task Force, Members. The
national agenda for quality palliative care: The National Consensus Project and
the National Quality Forum. [Review] Journal of Pain and Symptom
Management; 2007; 33:6 pp. 737-744. Retrieved at:
http://www.jpsmjournal.com/article/S0885-3924(07)00174-1/pdf

29
MEASURES THAT MATTER
Gao, W., Crosby, V., Wilcock, A., Burman, R., Silber, E., Hepgul, N., Chadhuri, K. R. &
Higginson, I. (2016). Psychometric properties of a generic, patient-centered
palliative care outcome measure of symptom burden of people with progressive
long-term neurological conditions. PLOS One Open Access Journal; 11:10
Published online Oct. 25, 2011. pp, 1-15. DOI: 10.1371/journal.pone.0165379.
Retrieved at:
http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0165379&ty
pe=printable
Gomes, B., Calazani, N., Curiale, V., McCrone, P. & Higginson, I. (2012). Effectiveness
and cost-effectiveness of home palliative care services for adults with advanced
illness and their caregivers. Cochrane Database of Systematic Reviews 2013,
Issue 6. Art No: CD007760 pp.1-22. DOI: 10.1002/14651858.CD007760.pub2.
Retrieved at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473359/
Hearn, J. & Higginson, I., on behalf of the Palliative Care Core Audit Project Advisory
Group (1999). Development and validation of a core outcome measure for
palliative care: the palliative care outcome scale. Quality in Health Care; 8:4 pp.
219-227. Retrieved at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483665/
Higginson, I., Hart, S., Koffman, J., Selman, L & Harding, R. (2007).Needs assessment
in palliative care: an appraisal of definitions and approaches used. Journal of Pain
and Symptom Management; 33:5 pp. 500-505. DOI:
10.1016/j.jpainsymman.2007.02.007 Retrieved at:
http://www.jpsmjournal.com/article/S0885-3924(07)00109-1/fulltext

30
MEASURES THAT MATTER
Institute of Healthcare Improvement (n.d.) Plan-do-study-act (psda) worksheet. Retrieved
at: http://www.ihi.org/resources/Pages/Tools/PlanDoStudyActWorksheet.aspx
Institute of Healthcare Improvement (n.d.) Triple aim for populations. Retrieved at:
http://www.ihi.org/Topics/TripleAim/Pages/default.aspx?gclid=EAIaIQobChMI_
NPb7_Wo2wIVwbrACh0ipgZFEAAYASAAEgJeHvD_BwE
Institute of Medicine (2016). The six domains of healthcare quality; Agency for
Healthcare Research and Quality. Rockville, MD. Retrieved at:
http://www.ahrq.gov/professionals/quality-patientsafety/talkingquality/create/sixdomains.html
Kane, P., Daveson, B., Ryan, K., Ellis-Smith, C., Mahon, N., McAdam, B., McQuillian,
R., et al. (2017). Feasibility and acceptability of a patient-reported outcome
intervention in chronic heart failure. BMJ Support Palliative Care: Retrieved at:
http://spcare.bmj.com/content/early/2017/09/01/bmjspcare-2017-001355.long
Leff, B., Carlson, C., Saliba, D. & Ritchie, C. (2015). The invisible homebound: setting
quality-of-care standards for home-based primary and palliative care. Health
Affairs; 34:1 pp. 21-29. DOI: 10.1377/hlthaff.2014.1008. Retrieved at:
http://www.healthaffairs.org/doi/abs/10.1377/hlthaff.2014.1008
Lorenz, K., Lynn, J., Dy, S., Wilkinson, A., Mularski, R., Shugarman, L., et al. (2006).
Quality measures for symptoms and advanced care planning in cancer: a
systematic review, Journal of Clinical Oncology; 24: 4933-4938. Retrieved at:
https://www.ncbi.nlm.nih.gov/pubmed/17050878

31
MEASURES THAT MATTER
Lowther, K., Simms, V., Selman, L., Sherr, L., Gwyther, L., Kariuki, H., et al. (2012).
Treatment outcomes in palliative care: the TOPCare study. A mixed methods
phase III radomised controlled trial to assess the effectiveness of a nurse-led
palliative care intervention for HIV positive patients on antiretroviral therapy
(2012). BMC Infectious Diseases; 12:288. Published online Nov. 6, 2012.
Retrieved at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538672/
Muldoon, M., Barger, S., Flory, J. & Manuck, S, (1998).What are quality of life
measurements measuring? British Medical Journal; 316: 542-545. Retrieved at:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2665651/pdf/9501721.pdf
Mulvihill, K., (Oct. 21, 2014). Palliative care? but I am not dying! Wolters Kluwer-Emmi
Solutions Blog Post. Retrieved at: https://www.emmisolutions.com/resource/blogpalliative-care-but-i-am-not-dying/
Murtagh, F., Ramsenthater, C., Firth, A., Groeneveld, E., Lovell, N., Simon, S., Denzel,
J., Bernhardt, F., Schildmann, E., Bauseweine, C. & Higginson, I. (2016). A brief
patient- and proxy-reported outcome measure for the adult palliative population:
validity and reliability of the integrated palliative outcome scale (IPOS). The
Cochrane Central Register of Controlled Trials (Central) 2017 Issue 2: pp. NP11.
Retrieved at:
https://www.onlinelibrary.wiley.com.ezproxy.umsl.edu/o/cochrane/clcentral/articl
es/430/CN-01304430/frame.html
National Consensus Project for Quality Palliative Care Guidelines 3rd edition (2013).
Retrieved at: https://www.nationalcoalitionhpc.org/ncp-guidelines-2013/

32
MEASURES THAT MATTER
POS: Palliative Care Outcome Scale (2012). Cecily Saunders Institute Kings College,
London, England. Retrieved at: https://www.pos-pal.org
Rugno, F. & Marysia, M (2016). The palliative outcome scale (POS) applied to clinical
practice and research: an integrative review. Revista Latino-Americana de
Enfermagem. On line version ISSN 1518-8345. Retrieved at:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996092/
Schildmann, E., Groeneveld, E.I., Denzel, J., Brown, A., Bernhardt, F., Bailey, K., et al.
(2015). Discovering the hidden benefits of cognitive interviewing in two
languages: the first phase of a validation study of the Integrated Palliative Care
Outcome Scale. Palliative Medicine; 30:6 pp. 599-610. DOI:
10.1177/0269216315608348. Retrieved at:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873725/
St. Louis University, Rapid Geriatric Screening Tool (2016). Retrieved at:

33
MEASURES THAT MATTER

Appendix

IPOS Patient Version
Patient name

: …………………………………………………

Date (dd/mm/yyyy) : …………………………………………………
Patient number

: ………………………………… (For staff use)

Q1. What have been your main problems or concerns over the
past 3 days?
1.
............................................................................................................
2.
............................................................................................................
3.
.............................................................................................................
Q2. Below is a list of symptoms, which you may or may not
have experienced. For each symptom, please tick one box that
best describes how it has affected you over the past 3 days.

Not at
all

Pain










Slightly










Moderately










Severely










Overwhelmingly










0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

Poor appetite

0

1

2

3

4

Constipation

0

1

2

3

4

0

1

2

3

4

Shortness of
breath
Weakness or
lack of energy
Nausea (feeling
like you are going
to be sick)

Vomiting
(being sick)

Sore or dry
mouth
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Drowsiness

0

1

2

3

4

Poor mobility

0

1

2

3

4

Please list any other symptoms not mentioned above, and tick
one box to show how they have affected you over the past 3
days.



1.

0



2.

0



3.

0



1



1



1

3

 
 



2

4

3



2

4

3

 



2

4

Over the past 3 days:

Not at
all
Q3. Have you
been feeling
anxious or
worried about
your illness or
treatment?
Q4. Have any of
your family or
friends been
anxious or
worried about
you?
Q5. Have you
been feeling
depressed?

Occasionally



1



1



1

0

0

0

Sometimes



2



2



2

Most of
the time



3



3



3

Always



4





4



4
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Always
Q6. Have you felt
at peace?
Q7. Have you
been able to
share how you
are feeling with
your family or
friends as much
as you wanted?
Q8. Have you
had as much
information as
you wanted?



1



1



1

0

0

0

Problems
addressed
/ No
problems

Q9. Have
any practical
problems
resulting
from your
illness been
addressed?
(such as
financial or
personal)

Q10. How did
you complete
this
questionnaire?

Most of the
time



0

Sometimes



2



2



2

Problems
mostly
addressed



1

Occasionally



3



3



3

Problems
partly
addressed



2

Not at all



4



4



4

Problems
hardly
addressed



3





Problems
not
addressed



4

On my
own

With help from a friend or relative

With help
from a
member
of staff







If you are worried about any of the issues raised on this questionnaire
then please speak to your doctor or nurse
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Appendix 2
IPOS Audit Tool
Date (dd/mm/yyyy) : ……………………… Admitting
Diagnosis……………………………. Provider Number:

Visit 1

Pain
Shortness of
breath
Weakne
ss or
lack of
energy
Nausea
(feeling
like you
are
going to
be sick)
Vomiting
(being
sick)
Poor
appetite
Constipa
-tion
Sore or
dry
mouth

Drowsiness

Poor
mobility

Visit 1

Visit 2

Visit 2

Provider
assessed
positive
symptom
y=yes,
n=no

Provider
intervention on
positive
symptom
y=yes,
n=no

 
 
 













 
 
 





























































 







 



 













 
 



















Provider
assessed
positive
symptom
y=yes,
n=no

Provider
intervention on
positive
symptom
y=yes,
n=no

Visit 3

Visit 3

Provider
assessed
positive
symptom
y=yes,
n=no

Provider
intervention on
positive
symptom
y=yes,
n=no

Visit 4
Provider
assessed
positive
symptom
y=yes,
n=no

Visit 4
Provider
Intervention
on positive
symptom
y=yes,
n=no

Additional Symptoms
1.

2.

3.
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Visit 1
Provider
assessed
positive
symptom
y=yes,
n=no

Q3. Have
you been
feeling
anxious or
worried
about your
illness or
treatment?
Q4. Have
any of your
family or
friends
been
anxious or
worried
about you?

Visit 1
Provider
intervention on
positive
symptom
y=yes,
n=no

Visit 2
Provider
assessed
positive
symptom
y=yes,
n=no

Visit 2
Provider
intervention on
positive
symptom
y=yes,
n=no

Visit 3
Provider
assessed
positive
symptom
y=yes,
n=no

Visit 3
Provider
intervention on
positive
symptom
y=yes,
n=no

Visit 4
Provider
assessed
positive
symptom
y=yes,
n=no

Visit 4
Provider
intervention
on positive
symptom
y=yes, n=no

   

  



   

  



Q5. Have
you been
feeling
depressed?

   

  



Q6. Have
you felt at
peace?

    

Q7. Have
you been
able to share
how you are
feeling with
your family
or friends as
much as you
wanted?

   

Q8. Have
you had as
much
informatio
n as you
wanted?

    

 



Q9. Have any
practical
problems
resulting
from your
illness been
addressed?
(such as
financial or
personal)

    

 



 



  



